feedback

Course Director

Lisa H. Lancaster, MD
Lisa H. Lancaster, MD

Vanderbilt University Medical Center
Nashville, Tennessee

Faculty

Marilyn K. Glassberg
Marilyn K. Glassberg, MD

University of Miami School of Medicine
Sylvester Comprehensive Cancer Center
Miami, Florida

Steven D. Nathan
Steven D. Nathan, MD

Inova Fairfax Hospital
Virginia Commonwealth University-Inova Fairfax Campus
Falls Church, Virginia

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME
Credit Amount:1.5 Credits
Release Date:2018-Jul-31
Expiration Date:2019-Jul-30
Estimated Time for Completion:1.5 hour
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

Optimal management of patients with interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), begins with accurate diagnosis and relies on safe and effective incorporation of newly approved and investigational therapies into individualized patient treatment paradigms. In this activity, experts in pulmonology discuss how to distinguish IPF and other ILDs via distinct radiographic patterns and pathologic features, explore late-breaking clinical data on approved and emerging regimens, and share strategies for applying evidence-based recommendations to optimize IPF management.

Upon completion of this activity, participants should be better able to:

  • Implement evidence-based strategies to differentiate radiologic imaging features of idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILDs)
  • Develop individualized IPF management plans based on shared decision-making and evidence-based recommendations for therapy
  • Evaluate emerging molecular markers for IPF diagnosis and investigational therapeutic strategies for IPF and ILDs

Target Audience

This activity has been designed to meet the educational needs of pulmonologists and other clinicians involved in the management of patients with interstitial lung disease.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: July 31, 2018 - July 30, 2019
Time to Complete: 90 minutes

Faculty and Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME activity during the past 12 months.

Course Director

Lisa H. Lancaster, MD
Medical Director Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis Program
Associate Professor of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Lisa H. Lancaster, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Genentech, Inc.
Grant/Research Support from Bellerophon Therapeutics; Celgene Corporation; and Galapagos NV.
Advisory Board for Bellerophon Therapeutics; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc.; and Global Blood Therapeutics Inc. (Whole Blood Therapeutics).
Other Financial or Material Support from Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, Inc. where Dr. Lancaster serves as a speaker for disease state presentations.
Lisa H. Lancaster, MD, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

Faculty

Marilyn K. Glassberg, MD
Director, Interstitial Lung Disease Program
Director, Pulmonary Diseases at Interdisciplinary Stem Cell Institute
Professor of Medicine, Surgery, and Pediatrics
Vice-Chairman of Medicine for Diversity and Innovation
University of Miami School of Medicine
Sylvester Comprehensive Cancer Center
Miami, Florida

Marilyn K. Glassberg, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from F. Hoffmann-La Roche Ltd/Genentech, Inc.
Advisory Board for Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd/Genentech, Inc.; Galapagos NV; and Patara Pharma.
Other Financial or Material Support from F. Hoffmann-La Roche Ltd/Genentech, Inc. for Data Safety Monitoring Board. Steering committee for Bellerophon Therapeutics and F. Hoffmann-La Roche Ltd/Genentech, Inc.
Marilyn K. Glassberg, MD, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

Steven D. Nathan, MD
Medical Director
Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Professor of Medicine
Virginia Commonwealth University-Inova Fairfax Campus
Falls Church, Virginia

Steven D. Nathan, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for F. Hoffmann-La Roche Ltd/Genentech, Inc.
Grant/Research Support from F. Hoffmann-La Roche Ltd/Genentech, Inc.
Speakers Bureau participant with Boehringer Ingelheim Pharmaceuticals, Inc.
Steven D. Nathan, MD, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

CME Reviewer

Howard J. Lee, MD

Howard J. Lee, MD, has no financial interests/relationships or affiliations in relation to this activity.

Medical Directors

Mary Mihalovic
PVI, PeerView Institute for Medical Education

Mary Mihalovic has no financial interests/relationships or affiliations in relation to this activity.

Chris Washburn, PhD
PVI, PeerView Institute for Medical Education

Chris Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit, and Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Providership



This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.